中文速读
本研究在K562细胞中,使用Entranster-R4000转染miR-223-3p mimic/inhibitor,研究miR-223-3p通过靶向TGFBR3/Smad信号通路调控红细胞生成,发现过表达miR-223-3p促进细胞增殖、抑制凋亡并增加血红蛋白水平。
体外(细胞)miRNA质粒DNAK562
MiR-223-3p regulates erythropoiesis by targeting TGFBR3/Smad signaling pathway in hemoglobin H-Constant Spring disease
Affiliation
- 1 Genetics and Precision Medicine Laboratory, Affiliated Hospital of Guilin Medical University, Guilin, China.
- PMID: 40646708
- PMCID: PMC12258197
- DOI: 10.1080/07853890.2025.2530690
Abstract
Background: MicroRNAs (miRNAs) have emerged as regulators of pathogenesis in hematopoiesis by targeting post-transcription mRNA regulation. However, the involvement of miRNAs in hemoglobin H-Constant Spring (HbH-CS) disease remains unclear. The present study analyzed miRNAs differential expression profile between patients with HbH-CS disease and healthy subjects by Arraystar Human small RNA Microarray.
Methods: The differential expression profiles of miRNAs between HbH-CS patients and healthy individuals were analyzed using Arraystar human small RNA microarrays. Quantitative real-time PCR and Western blot were used to detect the mRNA and protein expression. Bioinformatics methods were used to predict the target genes of miRNAs, and the regulatory relationship between miRNAs and target genes was verified by dual-luciferase reporter assay. Cell apoptosis was detected by flow cytometry, and cell proliferative capacity was detected by CC K-8 assay.
Results: MiR-223-3p was significantly down-regulated in HbH-CS patients. Dual-luciferase reporter assay demonstrated that miR-223-3p specifically targeted TGFBR3. The in vitro experiments showed that miR-223-3p inversely regulated the expression levels of TGFBR3, Smad2/3, and P-Smad2. We found that overexpression of miR-223-3p in K562 cells significantly promoted cellular proliferation and inhibited cellular apoptosis by suppressing expression of TGFBR3, Smad2/3, and P-Smad2. Moreover, up-regulation of miR-223-3p in induced K562 cells increased the expression levels of hemoglobin and mean corpuscular hemoglobin.
Conclusion: In conclusion, this study indicated that the interaction between miR-223-3p and TGFBR3/Smad signaling pathway might affect erythropoiesis in HbH-CS disease, which can provide more information for the treatment of patients.
Keywords: HbH-CS disease; TGFBR3; Thalassemia; miR-223-3p.
小核酸转染试剂Entranster™-R4000 已有 223 篇已发表文献
同类研究
- J Ovarian Res. 2026 Jul 31;19(1):330.doi: 10.1186/s13048-026-02215-6. Microfluidic lipid nanoparticles co-delivering siM…
- Front Immunol. 2026 May 29;17:1724930.doi: 10.3389/fimmu.2026.1724930. Machine learning-based identification of an oxida…
- Cell Calcium. 2026 Apr 19:135:103137.doi: 10.1016/j.ceca.2026.103137. TRPC1 channel modulates mechanical stretch-induced…
- Pharmaceuticals (Basel). 2026 Mar 27;19(4):540.doi: 10.3390/ph19040540. Identification of Dopamine D2 Receptor as a Dire…
- Viruses. 2026 Mar 5;18(3):323.doi: 10.3390/v18030323. Tree Shrew Genome-Wide CRISPR Screen Identifies RNF6 as a Proviral…